Wyeth Receives FDA Approval for New BeneFIX Features That Provide Hemophilia B Patients a Simpler and More Convenient ... (PR Newswire via Yahoo! Finance)
Wyeth Pharmaceuticals, a division of Wyeth , announced today that it has received approval from the U.S. Food and Drug Administration for new product enhancements for BeneFIX Coagulation Factor IX that will offer patients a simpler and more convenient preparation process compared with the original BeneFIX preparation process.

FDA Warning Letter Web Site Convicts Companies Unfairly (Medical Device Link)
An old saying has it that justice must not only be done, but it must be seen to be done. By this standard, FDA s warning letters Web page would seem to fail miserably.